Femcon Fe
FEMCON® Fe
(norethindrone and ethinyl estradiol) Tablets, Chewable and Ferrous Fumarate Tablets 0.4mg/35mcg
Ferrous fumarate tablets are not USP for dissolution and assay.
Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.
DRUG DESCRIPTION
FEMCON® Fe provides a regimen for oral contraception derived from 21 white tablets composed of norethindrone and ethinyl estradiol followed by 7 brown ferrous fumarate (placebo) tablets. The chemical name for norethindrone is 17-hydroxy-19-nor-17a-pregn-4-en-20-yn-3-one and for ethinyl estradiol the chemical name is 19-nor-17a-pregna-1,3,5(10)-trien-20-yne-3,17-diol. The structural formulas are:
 |
The active white FEMCON Fe tablets contain 0.4 mg norethindrone and 0.035 mg ethinyl estradiol, and the following inactive ingredients: dibasic calcium phosphate, lactose, magnesium stearate, maltodextrin, povidone, sodium starch glycolate, spearmint flavor and sucralose.
The brown tablets contain ferrous fumarate, microcrystalline cellulose, magnesium stereate, povidone, sodium starch glycolate, and compressible sugar. The ferrous fumarate tablets do not serve any therapeutic purpose.
Generic Name: Norethindrone and Ethinyl Estradiol Tablets
Women's Health
Find out what women really need.
Teens and STDs
Your kids are learning about AIDS and HIV in school, but what about other STDs?See more WebMD Videos »
Femcon Fe
New & Updated
2008 Election & Health Care on WebMD. Get Informed.
Updated & New
RxList does not provide medical advice, diagnosis or treatment.